1990
DOI: 10.1016/0049-0172(90)90048-k
|View full text |Cite
|
Sign up to set email alerts
|

Drug-induced myopathies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0
1

Year Published

1991
1991
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 65 publications
0
3
0
1
Order By: Relevance
“…Myopathy has rarely been reported with these agents [30] . Clinicians should be aware that treatment may lead to neuromyopathy as well as irreversible retinopathy with chronic use.…”
Section: Myopathymentioning
confidence: 99%
“…Myopathy has rarely been reported with these agents [30] . Clinicians should be aware that treatment may lead to neuromyopathy as well as irreversible retinopathy with chronic use.…”
Section: Myopathymentioning
confidence: 99%
“…Myopathy that is secondary to exposure to drugs or toxins, many of which are common, needs to be considered but in this case can be ruled out on the basis of the history. 4 In this patient, the signs, symptoms, and laboratory abnormalities suggest an inflammatory myopathy, examples of which include dermatomyositis, polymyositis, and inclusion-body myositis. [5][6][7][8][9] The myopathy that is typically seen in patients with scleroderma and the undifferentiated connectivetissue diseases seemed unlikely possibilities, because the patient had none of the specific stigmata associated with these diseases.…”
mentioning
confidence: 88%
“…For the vast majority of patients, statins are a safe and effective way of lowering the cholesterol level, but for a relatively small number of patients, myalgia is a recognized feature. Other drugs, including D‐penicillamine, have also been described to induce a polymyositis such as inflammatory myopathy (7). This link between statins and a necrotizing myopathy has been noted previously (8) and prompts consideration of the immunopathogenesis of myositis in general and in this newly recognized subset of patients in particular.…”
Section: Syndromes Associated With Myositis‐specific Autoantibodiesmentioning
confidence: 99%